ARVN Q1 2026 Earnings EPS Beats Expectations as Pipeline Advances Without Revenue Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path FHN Q1 2026 Earnings EPS Beats Estimates by Over 6 AEE Q1 2026 Earnings EPS Beats Estimates as Operational Strength Drives Performance CALM Q1 2026 Earnings Strong EPS Beat Amid Egg Market Dynamics Deere Q1 2026 Earnings Strong EPS Beat Amidst Weak Agricultural Demand